Heron Therapeutics announces publication of results from EPOCH 2, phase 3 study of HTX-011
Heron Therapeutics announced the results from EPOCH 2, a Phase 3 study of the investigational agent HTX-011 in open inguinal hernia repair surgery with mesh, have been published in the journal, Hernia. HTX-011 achieved all primary and key secondary endpoints in EPOCH 2. August 20, 2019